SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Repligen Corp (RGEN)
RGEN 162.38+3.0%Dec 19 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cheryl Galt who wrote (197)12/11/1999 9:42:00 PM
From: JMarcus  Read Replies (1) of 395
 
Cheryl, I think we should all congratulate ourselves on our savvy decision to buy RGEN on this dip, but don't put too much faith in the Rosenwald/Paramount/Aries purchases. We really don't know whether his research is any better than ours. He may just be taking the basket-buying approach: he's been buying up several other nano-cap biotechs too: e.g., DOR, GNTA, CYPB, AVXT, to name a few.

I own some of each, except CYPB, but I too am taking the basket-buying approach (only my basket is a nano-basket compared to Rosenwald's).

Marc
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext